CeCil: A randomized, noncomparative phase II clinical trial of the effect of radiation therapy (RT) plus temozolomide (TMZ) combined with cilengitide or cetuximab on the 1-year overall survival of patients with newly diagnosed MGMT-promoter unmethylated glioblastoma.
V. Verschaeve
No relevant relationships to disclose
L. A. D'Hondt
No relevant relationships to disclose
L. M. J. Verbeke
No relevant relationships to disclose
F. Van Fraeyenhove
No relevant relationships to disclose
S. Du Four
No relevant relationships to disclose
J. Duerinck
No relevant relationships to disclose
B. Neyns
Research Funding - Merck KGaA